Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05611307 · ClinicalTrials.gov registry record
Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors
A clinical trial, sponsored by Indiana University.
- Terminated
- Registry status
- 31
- Enrollment target
NCT05611307 is a clinical trial that was terminated before completion, run by Indiana University. The registered enrollment target is 31 participants.
The verdict
NCT05611307 was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- 31 participants
- Enrollment target
Study Summary
Late subclinical cardiovascular disease in testicular cancer survivors exposed to cisplatin-based chemotherapy and bone marrow transplant
Interventions
- DIAGNOSTIC_TEST Lipid profile
- DIAGNOSTIC_TEST Coronary artery assessment
- DIAGNOSTIC_TEST Hormone levels for hypogonadism
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2022-10-11 |
| Est. Completion | 2024-12-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05611307
The ClinicalTrials.gov registry entry for NCT05611307 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Lipid profile is the first listed.
NCT05611307 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05611307 about?
NCT05611307 is a clinical study titled "Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors". Late subclinical cardiovascular disease in testicular cancer survivors exposed to cisplatin-based chemotherapy and bone marrow transplant
What is the current status of trial NCT05611307?
This trial is currently terminated. The enrollment target is 31 participants. The study started on 2022-10-11. Estimated completion is 2024-12-04.
What interventions are being tested in trial NCT05611307?
The interventions under investigation include: Lipid profile (DIAGNOSTIC_TEST), Coronary artery assessment (DIAGNOSTIC_TEST), Hormone levels for hypogonadism (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05611307?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.